Edit |   |
---|---|
Product Name | Human LAG3 siRNA |
Description | siRNA to inhibit LAG3 expression using RNA interference. This product is provided as three 5 nmol vials (15 nmol) or 2x three 5 nmol vials (30 nmol) of lyophilized siRNA oligo duplexes. Each vial contains slightly different sequences to ensure full knockout of the gene. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Purity > 97%. |
Size | 15 nmol, 30 nmol |
Concentration | n/a |
Applications | RNAi |
Other Names | Lymphocyte Activation Gene 3, LAG3, Lymphocyte Activating 3, Lymphocyte-Activation Gene 3, CD223 Antigen, Protein FDC, CD223, LAG-3, FDC, Lymphocyte Activation Gene 3 siRNA, LAG3 siRNA, Lymphocyte Activating 3 siRNA, Lymphocyte-Activation Gene 3 siRNA, CD223 Antigen siRNA, Protein FDC siRNA, CD223 siRNA, LAG-3 siRNA, FDC siRNA |
Gene, Accession, CAS # | LAG3, Gene ID: 3902, UniProt: P18627 |
Catalog # | abx902922 |
Price | please inquire |
Order / More Info | Human LAG3 siRNA from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950